Comparative Effectiveness of Denosumab versus Zoledronic Acid Among Postmenopausal Women with Osteoporosis in the US Medicare Program

被引：0
|
作者：
Curtis, Jeffrey R. [1 ]
Arora, Tarun [2 ]
Liu, Ye [3 ]
Brunetti, Vanessa C. [4 ]
Lin, Tzu-Chieh [4 ]
Spangler, Leslie [4 ]
Stad, Robert K. [4 ]
McDermott, Michele [4 ]
Bradbury, Brian D. [4 ]
Kim, Min [4 ]
机构：
[1] Univ Alabama, Div Clin Immunol & Rheumatol, Birmingham, W Midlands, England
[2] Fdn Adv Sci Technol Educ & Res, Birmingham, W Midlands, England
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Amgen Inc, Thousand Oaks, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2529
引用
收藏
页码：5021 / 5022
页数：2
相关论文
共 50 条
  • [1] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ALENDRONATE AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J. R.
    Arora, T.
    Liu, Y.
    Lin, T. -C.
    Spangler, L.
    Brunetti, V. C.
    Stad, R. K.
    Mcdermott, M.
    Bradbury, B. D.
    Kim, M.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S55 - S56
  • [2] Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert K.
    McDermott, Michele
    Bradbury, Brian D.
    Kim, Min
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3979 - 3981
  • [3] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S580 - S580
  • [4] Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert Kees
    Mcdermott, Michele
    Bradbury, Brian D.
    Kim, Min
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (07) : 826 - 834
  • [5] Comparative Safety and Effectiveness of Denosumab versus Zoledronic Acid in Patients with Osteoporosis: A Cohort Study
    Choi, Nam-Kyong
    Solomon, Daniel H.
    Tsacogianis, Theodore N.
    Landon, Joan E.
    Song, Hong Ji
    Kim, Seoyoung C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 272 - 273
  • [6] Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study
    Choi, Nam-Kyong
    Solomon, Daniel H.
    Tsacogianis, Theodore N.
    Landon, Joan E.
    Song, Hong Ji
    Kim, Seoyoung C.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (03) : 611 - 617
  • [7] COST-EFFECTIVENESS COMPARISON OF DENOSUMAB AND ZOLEDRONIC ACID IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Ding, Y.
    Hay, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A47 - A47
  • [8] Administration Costs of Denosumab and Zoledronic Acid for Postmenopausal Osteoporosis
    Insinga, Ralph P.
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (03) : E42 - +
  • [9] Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Brown, J. P.
    Czerwinski, E.
    Nedergaard, B. S.
    Bolognese, M. A.
    Malouf, J.
    Bone, H. G.
    Reginster, J. -Y.
    Singer, A.
    Wang, C.
    Wagman, R. B.
    Cummings, S. R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (08): : 3163 - 3170
  • [10] Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US
    Parthan A.
    Kruse M.
    Yurgin N.
    Huang J.
    Viswanathan H.N.
    Taylor D.
    [J]. Applied Health Economics and Health Policy, 2013, 11 (5) : 485 - 497
12345